FOR IMMEDIATE RELEASE
April 21, 2023
Mynellies Negrón | +1 703 585 6727 | email@example.com
Chicago, IL — Today, the U.S. Supreme Court issued a ruling that will allow continued access to the drug mifepristone, one of two drugs used to prematurely terminate pregnancy. This ruling is part of a legal battle between lower courts and the Food and Drug Administration (FDA). Below is Alianza Americas’ response:
“We agree with the U.S. Supreme Court’s decision to preserve access to a drug that has guaranteed the human and reproductive right to terminate a pregnancy for decades. Restricting access to this drug would not only undermine the bodily autonomy of women, girls, and other pregnant individuals, but would endanger the lives of those who would be forced to resort to unregulated procedures,” said Nancy Treviño, Associate Director for Network Power at Alianza Americas.
This ruling signals hope after the shameful rollback to people’s reproductive rights following the overturning of federal abortion protections by this same Court in June of 2022. “This new attempt to further attack reproductive rights is a response to growing conservative and racist ideologies. If an unfavorable decision would have been issued, those who would be most affected would once again be working class people of color and migrant communities. We remain committed to our fight for the protection of our human rights and applaud and honor all those who continue to lead global movements for bodily autonomy and reproductive rights,” added Treviño.
Alianza Americas is the premier transnational advocacy network of Latin American migrant-led organizations working in the United States, across the Americas, and globally to create an inclusive, equitable and sustainable way of life for communities across North, Central and South America. In 2022, Alianza integrated with Presente.org, establishing a stronger digital organizing powerhouse.